Authors:
WANGCHOW F
FOX NL
BERIOLI S
BLUHMKI E
INGELHEIM B
MODI N
TANSWELL P
STUMP D
GIBSON CM
VANDEWERF F
Citation: F. Wangchow et al., A SIMPLE, INCREMENTAL WEIGHT-ADJUSTED DOSING SCHEME FOR TNK-TPA, A BIOENGINEERED VARIANT OF THE NATURAL TPA MOLECULE, Circulation, 98(17), 1998, pp. 1462-1462
Citation: P. Betremieux et al., SHOULD FRUSEMIDE BE PRESCRIBED AFTER PACKED RED-CELL TRANSFUSIONS IN THE NEWBORN, European journal of pediatrics, 156(2), 1997, pp. 88-89
Authors:
MOONCEY S
GIANNAKOULOPOULOS X
GLOVER V
ACOLET D
MODI N
Citation: S. Mooncey et al., THE EFFECT OF MOTHER-INFANT SKIN-TO-SKIN CONTACT ON PLASMA-CORTISOL AND BETA-ENDORPHIN CONCENTRATIONS IN PRETERM NEWBORNS, Infant behavior & development, 20(4), 1997, pp. 553-557
Citation: R. Carr et al., THE EFFECT ON NEUTROPHIL NUMBER, PHENOTYPE AND FUNCTION OF 5-DAY PROPHYLACTIC ADMINISTRATION OF GM-CSF TO PRETERM NEONATES, Blood, 90(10), 1997, pp. 768-768
Citation: W. Tang et al., ASSESSMENT OF TOTAL-BODY WATER USING BIOELECTRICAL-IMPEDANCE ANALYSISIN NEONATES RECEIVING INTENSIVE-CARE, Archives of Disease in Childhood, 77(2), 1997, pp. 123-126
Citation: W. Tang et al., INFLUENCE OF RESPIRATORY-DISTRESS SYNDROME ON BODY-COMPOSITION AFTER PRETERM BIRTH, Archives of Disease in Childhood, 77(1), 1997, pp. 28-31
Citation: R. Carr et N. Modi, HEMATOPOIETIC COLONY-STIMULATING FACTORS FOR PRETERM NEONATES, Archives of Disease in Childhood, 76(2), 1997, pp. 128-133
Citation: N. Modi et C. Kirubakaran, REASONS FOR ADMISSION, CAUSES OF DEATH AND COSTS OF ADMISSION TO A TERTIARY REFERRAL NEONATAL UNIT IN INDIA, Journal of tropical pediatrics, 41(2), 1995, pp. 99-102
Authors:
MOONCEY S
GIANNAKOULOPOULOS X
MODI N
GLOVER V
Citation: S. Mooncey et al., THE EFFECT OF NONPHARMACOLOGICAL TREATMENTS ON CIRCULATING CORTISOL AND BETA-ENDORPHIN IN PRETERM BABIES, Pediatric research, 38(3), 1995, pp. 445-445
Authors:
REFINO C
MODI N
BULLENS S
PATER C
LIPARI T
WU D
BLACKBURN B
WELLER T
STEINER B
BUNTING S
Citation: C. Refino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF A POTENT, NONPEPTIDIC, GP IIB-IIIA RECEPTOR ANTAGONIST (RO-44-3888) FOLLOWING ORAL-ADMINISTRATION OF A PRODRUG FORM (RO-48-3657) TO RHESUS-MONKEYS, Blood, 86(10), 1995, pp. 348-348
Authors:
PAYNE DW
WILLIAMSON ED
HAVARD H
MODI N
BROWN J
Citation: Dw. Payne et al., EVALUATION OF A NEW CYTOTOXICITY ASSAY FOR CLOSTRIDIUM-PERFRINGENS TYPE-D EPSILON-TOXIN, FEMS microbiology letters, 116(2), 1994, pp. 161-167
Citation: W. Tang et al., ASSESSMENT OF TOTAL-BODY WATER AND WEIGHT IN NEONATES USING BIOELECTRICAL-IMPEDANCE ANALYSIS, Pediatric research, 36(1), 1994, pp. 10000029-10000029